Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

When insights from pharma help fight fungus

Posted on March 24th, 2020 by in Pharma R&D

Fungicide resistance is a growing problem, as evidenced by publication trends. Publications on this issue are particularly high across the world’s major economies, and many focus specifically on the fungus Botrytis.

(more…)

How can we get pharma R&D to embrace FAIR data?

Posted on January 6th, 2020 by in Pharma R&D

FAIR data, which is Findable, Accessible, Interoperable and Reusable, has the power to transform the analyses enabling drug discovery and development—yet, the pharma industry has been slow to adopt it. There are a number of reasons for this unfortunate reality, but there is a path to realizing the potential for FAIR data in pharmaceutical R&D.

(more…)

AI in Drug Discovery Has Great Potential – But Also Significant Barriers

Posted on May 1st, 2019 by in Pharma R&D

Elsevier’s Tim Miller’s article in World Pharma Today provides a insightful lens into the reality behind the complexities of implementing artificial intelligence into the R&D cycle. While great strides have been made, the runway to realize the potential is a long one and there are many exciting discoveries left to be made and obstacles to overcome.

(more…)

Emulating start-up success with purpose-built data tools

Posted on December 12th, 2018 by in Pharma R&D

Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. (more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 13